TA
AGRX

Teachers Advisors’s Agile Therapeutics AGRX Stock Holding History

Teachers Advisors’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15
Closed -$98K – 3191
2017
Q1 		$98K Buy
15
+5
+50% +$25.1K ﹤0.01% 2983
2016
Q4 		$111K Hold
10
– – ﹤0.01% 2998
2016
Q3 		$135K Hold
10
– – ﹤0.01% 2972
2016
Q2 		$148K Buy
10
+3
+43% +$41.1K ﹤0.01% 2986
2016
Q1 		$93K Hold
7
– – ﹤0.01% 2955
2015
Q4 		$145K Hold
7
– – ﹤0.01% 2957
2015
Q3 		$100K Hold
7
– – ﹤0.01% 3007
2015
Q2 		$128K Buy
+7
New +$149K ﹤0.01% 3038

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Teachers Advisors's AGRX Position: Q2 2017 in Review

Teachers Advisors sold out of Agile Therapeutics (AGRX) in Q2 2017, closing a stake of 15 shares — an estimated $98K sold.

Teachers Advisors first reported a position in AGRX in Q2 2015 and held it in 8 quarters. The position peaked at $148K in Q2 2016. 41 funds tracked by Wall St. Rank hold AGRX as of Q2 2017.

  • Teachers Advisors reported no remaining Agile Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Teachers Advisors sold 15 Agile Therapeutics shares in Q2 2017, an estimated $98K.
  • Teachers Advisors first reported a position in Agile Therapeutics in Q2 2015 and held it in 8 quarters.
  • Teachers Advisors's Agile Therapeutics position peaked at $148K in Q2 2016.
  • 41 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.